Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Meningioma × Cyclophosphamide × Clear all

Phase

Status

Completed 2 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 50 Lymphoma, Large B-Cell, Diffuse 33 Leukemia, Myeloid, Acute 33 Breast Neoplasms 31 Lymphoma, Non-Hodgkin 27 Lymphoma 27 Multiple Myeloma 26 Burkitt Lymphoma 26 Lymphoma, B-Cell 22 Myelodysplastic Syndromes 21 Hematologic Neoplasms 21 Lymphoma, Follicular 20 Recurrence 17 Triple Negative Breast Neoplasms 16 Melanoma 15 Leukemia, Lymphocytic, Chronic, B-Cell 15 Leukemia 14 Pancreatic Neoplasms 11 Ovarian Neoplasms 10 Neoplasms 10 Neoplasm Metastasis 10 Lymphoma, Mantle-Cell 10 Lymphoma, B-Cell, Marginal Zone 10 Hodgkin Disease 10 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9 Leukemia, Myelomonocytic, Chronic 9 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 9 Leukemia, Biphenotypic, Acute 9 Neuroblastoma 8 Lymphoma, T-Cell, Peripheral 8

Interventions

Magnetic Resonance Spectroscopy 6 lutetium Lu 177 dotatate 5 Specimen Handling 4 Proton Therapy 3 Everolimus 3 pembrolizumab 2 gallium Ga 68 dotatate 2 abemaciclib 2 Sunitinib 2 Radiosurgery 2 Protons 2 Observation 2 Hydroxyurea 2 Ga(III)-DOTATOC 2 Elasticity Imaging Techniques 2 Bevacizumab 2 trametinib 1 regorafenib 1 olaparib 1 fludarabine 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 capivasertib 1 cabozantinib 1 auricularum 1 apatinib 1 X-Rays 1 Watchful Waiting 1 Thrombectomy 1 Tablets 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06640582 2024-11-05

BAH2472

Essen Biotech

Phase 1/2 Recruiting

Brain Neoplasms, Glioblastoma, Glioma, Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡